-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: cancer
Cancer Stem Cell Therapy: Real Or Just Hype?
Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem cells of self-renewal and differentiation, thereby causing tumor relapse and/or metastatis. While traditional cancer treatments focus on tumor shrinkage, it’s a distinct possibility that these agents do not effectively destroy all of the CSCs, causing the tumor to reappear. The CSC theory is relatively new, so the treatment pipeline is still in its early stages. Nathan Sadeghi-Nejad, a contributor to Read More >
Childhood Cancer Groups Join Forces to Train Childhood Cancer Leaders
Cancer remains the leading cause of death by disease for children in the United States today. Each year, about 13,500 children are diagnosed with cancer—more than a schoolroom of children every day. September is National Childhood Cancer Awareness Month in the U.S., and our organizations are drawing attention to these devastating diseases by training advocates to take action to change the future for children with cancer. While the five-year survival rates of some childhood cancers have improved, Read More >
Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree
Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree. Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >
Meet 2011′s Buzz of BIO Winner, Amrita Therapeutics
2011 Buzz of BIO Health Winner Amrita Therapeutics is a bio-pharma discovery company based in Ahmedabad, Gujarat, pursuing the development of novel, multiple disease targeting therapies for cancer. Last year, they won the Buzz of BIO Contest for the 2011 BIO International Convention, where industry executives and leaders voted on their favorite biotech companies. BIO recently spoke with Susan Finston, the CEO of Amrita Therapeutics, to get their thoughts on the contest, last year’s BIO Read More >
Oncology Clinical Trials – Secrets of Success
At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that drugs in development for oncology indications had the lowest overall clinical trial success rate of all therapeutic areas in development since 2004. We have updated these numbers to include clinical trials through December 2011. Although overall success rates did improve slightly, oncology remained in last place. The chart below illustrates why oncology’s overall success rate is so low relative to Read More >
